0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

Pathophysiological Aspects

Session 4: Pathophysiological Aspects

Koen Paemeleire

Professor, Department of Neurology in Ghent University Hospital, Belgium

Download presentation

Next

Epidemiological and clinical aspects

You Might Also Like

Related Embedded Video Item Thumbnail Safety and tolerability, wearing-off
Related Embedded Video Item Thumbnail Genetic aspects and latest findings
Related Embedded Video Item Thumbnail Combination therapy and switching
Related Embedded Video Item Thumbnail Impact on patients
Related Embedded Video Item Thumbnail Targeting ion channels

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct

Norway, Finland, Denmark: AJO-DK-NP-00128